Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer.

J Immunother Cancer · 2024 · PMC11575314 · PMID 39542655

Europe PMC DOI

hedged sentence

0.3120

closest p · 6.2× alpha

0.3120

boldest claim

The sentences

showed a trendp=0.312not close (p > 0.1)

Comparison of the pre/post CKM/paclitaxel mRNAs showed a trend towards an overall increase in CD8α (average 6.88-fold/median 2.86-fold; p=0.312) and an average 5.9-fold/median 5.39-fold increase in CD8β (p=0.094).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.